Oragenics prices $16.5M offering of Series H preferred units at $25.00 each

Filed July 2, 2025 · ~1 min read

Key Changes

• high

  Oragenics is offering 660,000 units at $25.00 per unit, each consisting of one share of Series H convertible preferred stock and a warrant to purchase one additional preferred share.

  The Offering verify on EDGAR →
• high

  Gross proceeds to the company are $16.5 million before deducting placement agent fees of $1.155 million and estimated offering expenses of $350,000, resulting in net proceeds of approximately $15.0 million.

  The Offering verify on EDGAR →
• high

  The company has received deficiency letters from NYSE American for non-compliance with continued listing standards and must regain compliance by October 18, 2025 to avoid delisting.

  The Offering verify on EDGAR →